Medication Management

Do antihypertensive classes differ in adverse effect rates leading to discontinuation?
Study identifies which of the five major antihypertensive drug classes is associated with the lowest rates of medication discontinuation due to adverse events.
Buy now, pay later
People often suffer from a recurrence of their bipolar illness because of non-compliance with the prescribed treatment, but in this case Stan thought that Melanie had been taking it as ordered.

A question of pressure

Sometimes knowing a patient for years and years can gum up the works when figuring out a puzzling diagnosis.
De-coding prescribing cascades

A case-based reflective approach to help you identify and manage potentially inappropriate prescribing cascades.
Too many, and then it was too late: how an enema mistake led to a patient’s death

A new ISMP Canada safety bulletin offers practical steps health systems can take to prevent similar errors from happening again.
What a day!

(Dolupo is the winner of our 2026 essay contest for International Pharmacy Graduates.) Good morning, Pictou County! It was August 29th.
Pharmacists are seeing the gaps in care. So how can they close them?

At BCPhA’s annual conference, Ajit Johal said pharmacists were uniquely positioned to catch patients falling through the cracks of chronic disease management and preventative care.
Saskatchewan’s new deal is betting big on pharmacists to ease healthcare strain

Pharmacy Association of Saskatchewan CEO Michael Fougere says the province’s new $13.8-million agreement will push pharmacists deeper into frontline care through expanded testing and medication reviews.
What’s driving pressure on private drug plans today?

Just released trends report highlights growing impact of chronic disease and specialty treatments on plan sustainability.
Asthma Canada updates Asthma Action Plans for adults and children

Healthcare professionals should assist patients with completing an asthma action plan to help them take control of their asthma and respond quickly when symptoms change.
What I wish prescribers knew about compounding

A pharmacist's honest, friendly note to the clinicians we work with every day.
The era of the $250,000 drug is here—and payers are worried

At BCPHA’s annual conference, insurers and government officials discussed how rising drug costs, GLP-1s and chronic disease are reshaping the future of pharmacy care.

Do antihypertensive classes differ in adverse effect rates leading to discontinuation?

Buy now, pay later

A question of pressure

De-coding prescribing cascades

Too many, and then it was too late: how an enema mistake led to a patient’s death

What a day!

Pharmacists are seeing the gaps in care. So how can they close them?

Saskatchewan’s new deal is betting big on pharmacists to ease healthcare strain

What’s driving pressure on private drug plans today?

Asthma Canada updates Asthma Action Plans for adults and children

What I wish prescribers knew about compounding

The era of the $250,000 drug is here—and payers are worried